Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Update

Straumann Holding AG (OTCMKTS:SAUHYGet Free Report) was the recipient of a large decline in short interest during the month of March. As of March 13th, there was short interest totaling 19,458 shares, a decline of 67.0% from the February 26th total of 58,892 shares. Based on an average trading volume of 767,686 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s shares are short sold.

Straumann Price Performance

SAUHY stock opened at $10.22 on Friday. The company’s 50-day moving average is $11.61 and its 200-day moving average is $11.65. Straumann has a 1 year low of $9.44 and a 1 year high of $14.18.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Citigroup reaffirmed a “sell” rating on shares of Straumann in a research report on Wednesday, January 14th. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research note on Monday, December 15th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold”.

Check Out Our Latest Report on SAUHY

Straumann Company Profile

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

Read More

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.